Business
Medicare Deal for Obesity Drugs
Novo Nordisk and Eli Lilly may be receiving better terms than expected from Medicare’s Bridge program, which covers obesity drugs for seniors at a reduced rate of $245 per month.
Coverage timeline — 1 article
STAT News
Eli Lilly and Novo Nordisk were already benefitting a great deal from the Trump administration's pilot program covering obesity drugs for seniors at a price of $245 a month. It…
2026-09-22 14:23 UTC